Evidence map›Paper›PMID 28973315›Full record

Trial reportInvestigative ophthalmology & visual science2017

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.

Dibyendu Mukherjee, Eleonora M Lad, Ryan R Vann, Stephanie J Jaffe, Traci E Clemons, Martin Friedlander, Emily Y Chew, Glenn J Jaffe, Sina Farsiu, MacTel Study Group

Abstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Investigative ophthalmology & visual science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2021
    Review
  17. Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2021
    Review
  18. Article
  19. Article
  20. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dibyendu MukherjeeDepartment of Biomedical Engineering, Duke University Medical Center, Durham, North Carolina, United States.
Eleonora M LadDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States.
Ryan R VannResearch Triangle High School, Durham, North Carolina, United States.
Stephanie J JaffeTrinity College, Duke University, Durham, North Carolina, United States.
Traci E ClemonsOphthalmology, EMMES, Rockville, Maryland, United States.
Martin FriedlanderDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States.
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, Bethesda, Maryland, United States.
Glenn J JaffeDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States.
Sina FarsiuDepartment of Biomedical Engineering, Duke University Medical Center, Durham, North Carolina, United States.
MacTel Study Group

Funding

Monocytes in Dry Age-Related Macular DegenerationK23EY026988 · NEI · DUKE UNIVERSITY · PI LAD, ELEONORA GEORGETA · 2016 to 2018
$420k
NEI NIH HHS K23 EY026988
6 · The paper itself

Abstract

Purpose: To correlate ellipsoid zone (EZ) defects on spectral-domain optical coherence tomography (SD-OCT) with retinal sensitivity loss on macular integrity assessment (MAIA) microperimetry in macular telangiectasia type 2 (MacTel). Methods: Macular SD-OCT volumes and microperimetry maps were obtained during the international, multicenter, randomized phase 2 trial of ciliary neurotrophic factor for type 2 MacTel on two visits within 5 days of one another. Software was developed to register SD-OCT to MAIA scanning laser ophthalmoscopy images and to overlay EZ defect areas on the microperimetry maps generated from microperimetry sensitivity values at specific points and from interpolated sensitivity values. A total of 134 eyes of 67 patients were investigated. Results: The semiautomated registration algorithm was found to be accurate, both qualitatively by visual inspection of the nearly perfect overlap of the retinal vessels and quantitatively as assessed by interobserver reliability metrics performed in 98 eyes of 49 patients (intraclass correlation of aggregate retinal sensitivity loss >0.99). Aggregate retinal sensitivity loss within the EZ defect area was highly correlated with EZ defect area (Pearson correlation coefficient 0.93 and 0.92 at screening and baseline for noninterpolated maps; both were 0.94 for interpolated maps; P values <0.001). Conclusions: With our software and image processing algorithms, there is nearly perfect correlation between retinal sensitivity on microperimetry and EZ defect area on SD-OCT. Our software allows determination of functional and structural changes with increasing disease severity and demonstrates that functional loss on microperimetry may be used as a surrogate marker of EZ loss on SD-OCT in type 2 MacTel.

Indexed as

AlgorithmsAgedCiliary Neurotrophic FactorFemaleHumansMacula LuteaMaleMiddle AgedReproducibility of ResultsRetinal TelangiectasisSensory ThresholdsSoftwareTomography, Optical CoherenceVisual AcuityVisual FieldsVisual Field TestsCiliary Neurotrophic Factor

Identifiers

PMID28973315
PMCPMC6024664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.